Skip to main content
Top
Published in: Diabetologia 6/2018

Open Access 01-06-2018 | Article

Overweight, obesity and the risk of LADA: results from a Swedish case–control study and the Norwegian HUNT Study

Published in: Diabetologia | Issue 6/2018

Login to get access

Abstract

Aims/hypothesis

Excessive weight is a risk factor for type 2 diabetes, but its role in the promotion of autoimmune diabetes is not clear. We investigated the risk of latent autoimmune diabetes in adults (LADA) in relation to overweight/obesity in two large population-based studies.

Methods

Analyses were based on incident cases of LADA (n = 425) and type 2 diabetes (n = 1420), and 1704 randomly selected control participants from a Swedish case–control study and prospective data from the Norwegian HUNT Study including 147 people with LADA and 1,012,957 person-years of follow-up (1984–2008). We present adjusted ORs and HRs with 95% CI.

Results

In the Swedish data, obesity was associated with an increased risk of LADA (OR 2.93, 95% CI 2.17, 3.97), which was even stronger for type 2 diabetes (OR 18.88, 95% CI 14.29, 24.94). The association was stronger in LADA with low GAD antibody (GADA; <median) (OR 4.25; 95% CI 2.76, 6.52) but present also in LADA with high GADA (OR 2.14; 95% CI 1.42, 3.24). In the Swedish data, obese vs normal weight LADA patients had lower GADA levels, better beta cell function, and were more likely to have low-risk HLA-genotypes. The combination of overweight and family history of diabetes (FHD) conferred an OR of 4.57 (95% CI 3.27, 6.39) for LADA and 24.51 (95% CI 17.82, 33.71) for type 2 diabetes. Prospective data from HUNT indicated even stronger associations; HR for LADA was 6.07 (95% CI 3.76, 9.78) for obesity and 7.45 (95% CI 4.02, 13.82) for overweight and FHD.

Conclusions/interpretation

Overweight/obesity is associated with increased risk of LADA, particularly when in combination with FHD. These findings support the hypothesis that, even in the presence of autoimmunity, factors linked to insulin resistance, such as excessive weight, could promote onset of diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abdullah A, Peeters A, de Courten M, Stoelwinder J (2010) The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 89:309–319CrossRefPubMed Abdullah A, Peeters A, de Courten M, Stoelwinder J (2010) The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 89:309–319CrossRefPubMed
3.
go back to reference Wilkin TJ (2009) The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes 33:716–726CrossRef Wilkin TJ (2009) The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes 33:716–726CrossRef
4.
go back to reference Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661–1667CrossRefPubMed Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661–1667CrossRefPubMed
5.
go back to reference Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, Diabetes Prevention Trial-Type 1 Study Group (2007) Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30:2314–2320CrossRefPubMed Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, Diabetes Prevention Trial-Type 1 Study Group (2007) Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30:2314–2320CrossRefPubMed
6.
go back to reference Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y (2014) Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 13:981–1000CrossRefPubMed Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y (2014) Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 13:981–1000CrossRefPubMed
7.
go back to reference Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28:10–18CrossRefPubMed Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28:10–18CrossRefPubMed
8.
go back to reference Harpsoe MC, Basit S, Andersson M et al (2014) Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol 43:843–855CrossRefPubMed Harpsoe MC, Basit S, Andersson M et al (2014) Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol 43:843–855CrossRefPubMed
9.
go back to reference Meah FA, DiMeglio LA, Greenbaum CJ et al (2016) The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants. Diabetologia 59:1186–1195CrossRefPubMedPubMedCentral Meah FA, DiMeglio LA, Greenbaum CJ et al (2016) The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants. Diabetologia 59:1186–1195CrossRefPubMedPubMedCentral
10.
go back to reference Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, Group ES (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027–2033CrossRefPubMed Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, Group ES (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027–2033CrossRefPubMed
12.
go back to reference Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383:1084–1094CrossRefPubMed Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383:1084–1094CrossRefPubMed
13.
go back to reference Tuomi T, Carlsson A, Li H et al (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157CrossRefPubMed Tuomi T, Carlsson A, Li H et al (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157CrossRefPubMed
14.
go back to reference Lohmann T, Kellner K, Verlohren HJ et al (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005–1010CrossRefPubMed Lohmann T, Kellner K, Verlohren HJ et al (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005–1010CrossRefPubMed
15.
go back to reference Pes GM, Delitala AP, Delitala G, Errigo A, Costantino S, Fanciulli G (2014) Phenotypic heterogeneity of latent autoimmune diabetes in adults identified by body composition analysis. Diabetol Metab Syndr 6:128CrossRefPubMedPubMedCentral Pes GM, Delitala AP, Delitala G, Errigo A, Costantino S, Fanciulli G (2014) Phenotypic heterogeneity of latent autoimmune diabetes in adults identified by body composition analysis. Diabetol Metab Syndr 6:128CrossRefPubMedPubMedCentral
16.
go back to reference Maioli M, Pes GM, Delitala G et al (2010) Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Eur J Endocrinol 163:541–549CrossRefPubMed Maioli M, Pes GM, Delitala G et al (2010) Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Eur J Endocrinol 163:541–549CrossRefPubMed
17.
go back to reference Hawa MI, Buchan AP, Ola T et al (2014) LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes. Diabetes Care 37:1643–1649CrossRefPubMed Hawa MI, Buchan AP, Ola T et al (2014) LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes. Diabetes Care 37:1643–1649CrossRefPubMed
18.
go back to reference Buzzetti R, Di Pietro S, Giaccari A et al (2007) High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932–938CrossRefPubMed Buzzetti R, Di Pietro S, Giaccari A et al (2007) High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932–938CrossRefPubMed
19.
go back to reference Zhou Z, Xiang Y, Ji L et al (2013) Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes 62:543–550CrossRefPubMedPubMedCentral Zhou Z, Xiang Y, Ji L et al (2013) Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes 62:543–550CrossRefPubMedPubMedCentral
20.
go back to reference Carlsson S, Midthjell K, Tesfamarian MY, Grill V (2007) Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trondelag health study. Diabetologia 50:55–58CrossRefPubMed Carlsson S, Midthjell K, Tesfamarian MY, Grill V (2007) Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trondelag health study. Diabetologia 50:55–58CrossRefPubMed
21.
go back to reference Wikner C, Gigante B, Hellenius ML, de Faire U, Leander K (2013) The risk of type 2 diabetes in men is synergistically affected by parental history of diabetes and overweight. Plos One 8 Wikner C, Gigante B, Hellenius ML, de Faire U, Leander K (2013) The risk of type 2 diabetes in men is synergistically affected by parental history of diabetes and overweight. Plos One 8
22.
go back to reference Lofvenborg JE, Andersson T, Carlsson PO et al (2014) Coffee consumption and the risk of latent autoimmune diabetes in adults--results from a Swedish case-control study. Diabet Med 31:799–805CrossRefPubMed Lofvenborg JE, Andersson T, Carlsson PO et al (2014) Coffee consumption and the risk of latent autoimmune diabetes in adults--results from a Swedish case-control study. Diabet Med 31:799–805CrossRefPubMed
23.
go back to reference Vandenbroucke JP, Pearce N (2012) Case-control studies: basic concepts. Int J Epidemiol 41:1480–1489CrossRefPubMed Vandenbroucke JP, Pearce N (2012) Case-control studies: basic concepts. Int J Epidemiol 41:1480–1489CrossRefPubMed
24.
go back to reference Rahmati K, Lernmark A, Becker C et al (2008) A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits. Clin Lab 54:227–235PubMed Rahmati K, Lernmark A, Becker C et al (2008) A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits. Clin Lab 54:227–235PubMed
25.
go back to reference Andersen MK, Lundgren V, Turunen JA et al (2010) Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 33:2062–2064CrossRefPubMedPubMedCentral Andersen MK, Lundgren V, Turunen JA et al (2010) Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 33:2062–2064CrossRefPubMedPubMedCentral
26.
go back to reference Nguyen C, Varney MD, Harrison LC, Morahan G (2013) Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62:2135–2140CrossRefPubMedPubMedCentral Nguyen C, Varney MD, Harrison LC, Morahan G (2013) Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62:2135–2140CrossRefPubMedPubMedCentral
28.
go back to reference Sepp H, Ekelund U, Becker W (2004) Enkätfrågor om kost och fysisk aktivitet bland vuxna. Livsmedelverket, rapport 21 [article in Swedish] Sepp H, Ekelund U, Becker W (2004) Enkätfrågor om kost och fysisk aktivitet bland vuxna. Livsmedelverket, rapport 21 [article in Swedish]
29.
go back to reference Krokstad S, Langhammer A, Hveem K et al (2013) Cohort Profile: the HUNT Study, Norway. Int J Epidemiol 42:968–977CrossRefPubMed Krokstad S, Langhammer A, Hveem K et al (2013) Cohort Profile: the HUNT Study, Norway. Int J Epidemiol 42:968–977CrossRefPubMed
30.
go back to reference Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G (1992) Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Community Health 46:537–542CrossRefPubMedPubMedCentral Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G (1992) Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Community Health 46:537–542CrossRefPubMedPubMedCentral
31.
go back to reference Radtke MA, Midthjell K, Nilsen TI, Grill V (2009) Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trondelag Health (HUNT) study. Diabetes Care 32:245–250CrossRefPubMedPubMedCentral Radtke MA, Midthjell K, Nilsen TI, Grill V (2009) Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trondelag Health (HUNT) study. Diabetes Care 32:245–250CrossRefPubMedPubMedCentral
32.
go back to reference Browning LM, Hsieh SD, Ashwell M (2010) A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 23:247–269CrossRefPubMed Browning LM, Hsieh SD, Ashwell M (2010) A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 23:247–269CrossRefPubMed
33.
go back to reference Orsini N, Greenland S (2011) A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J 11:1–29 Orsini N, Greenland S (2011) A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J 11:1–29
34.
go back to reference Rothman KJ, Greenland S (1998) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia Rothman KJ, Greenland S (1998) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia
35.
go back to reference Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A (2005) Calculating measures of biological interaction. Eur J Epidemiol 20:575–579CrossRefPubMed Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A (2005) Calculating measures of biological interaction. Eur J Epidemiol 20:575–579CrossRefPubMed
36.
go back to reference Greenland S (2015) Concepts and pitfalls in measuring and interpreting attributable fractions, prevented fractions, and causation probabilities. Ann Epidemiol 25:155–161CrossRefPubMed Greenland S (2015) Concepts and pitfalls in measuring and interpreting attributable fractions, prevented fractions, and causation probabilities. Ann Epidemiol 25:155–161CrossRefPubMed
37.
go back to reference Brahmkshatriya PP, Mehta AA, Saboo BD, Goyal RK (2012) Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA). ISRN Pharmacol 2012:580202CrossRefPubMedPubMedCentral Brahmkshatriya PP, Mehta AA, Saboo BD, Goyal RK (2012) Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA). ISRN Pharmacol 2012:580202CrossRefPubMedPubMedCentral
38.
go back to reference Leslie RD, Kolb H, Schloot NC et al (2008) Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 24:511–519CrossRefPubMed Leslie RD, Kolb H, Schloot NC et al (2008) Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 24:511–519CrossRefPubMed
39.
go back to reference Zinman B, Kahn SE, Haffner SM et al (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193–3200CrossRefPubMed Zinman B, Kahn SE, Haffner SM et al (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193–3200CrossRefPubMed
40.
go back to reference Islam ST, Srinivasan S, Craig ME (2014) Environmental determinants of type 1 diabetes: a role for overweight and insulin resistance. J Paediatr Child Health 50:874–879CrossRefPubMed Islam ST, Srinivasan S, Craig ME (2014) Environmental determinants of type 1 diabetes: a role for overweight and insulin resistance. J Paediatr Child Health 50:874–879CrossRefPubMed
41.
go back to reference Cedillo M, Libman IM, Arena VC et al (2015) Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes. J Clin Endocrinol Metab 100:E82–E86CrossRefPubMed Cedillo M, Libman IM, Arena VC et al (2015) Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes. J Clin Endocrinol Metab 100:E82–E86CrossRefPubMed
42.
go back to reference Hjort R, Alfredsson L, Andersson T et al (2017) Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). Diabete Metab 43:536–542CrossRefPubMed Hjort R, Alfredsson L, Andersson T et al (2017) Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). Diabete Metab 43:536–542CrossRefPubMed
43.
go back to reference Gale EA (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195–2199CrossRefPubMed Gale EA (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195–2199CrossRefPubMed
44.
go back to reference Sorgjerd EP, Skorpen F, Kvaloy K, Midthjell K, Grill V (2012) Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway. Diabetologia 55:1310–1318CrossRefPubMed Sorgjerd EP, Skorpen F, Kvaloy K, Midthjell K, Grill V (2012) Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway. Diabetologia 55:1310–1318CrossRefPubMed
45.
go back to reference Hawa MI, Kolb H, Schloot N et al (2013) Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 36:908–913CrossRefPubMedPubMedCentral Hawa MI, Kolb H, Schloot N et al (2013) Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 36:908–913CrossRefPubMedPubMedCentral
46.
go back to reference Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed
Metadata
Title
Overweight, obesity and the risk of LADA: results from a Swedish case–control study and the Norwegian HUNT Study
Publication date
01-06-2018
Published in
Diabetologia / Issue 6/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4596-0

Other articles of this Issue 6/2018

Diabetologia 6/2018 Go to the issue